Highlights
A collection of news and information related to Vivus Inc. published by this site and its partners.
Displaying items 1-12 of 13
» View wsbtradio.com items only
1
2
•
Next >
-
Denner added as nominee to Vivus board by activist investor
ReutersBy Bill Berkrot May 23 (Reuters) - First Manhattan Company (FMC) added some heavyweight muscle on Thursday to its bid to shake up the board of drugmaker Vivus Inc by naming former Carl Icahn top lieutenant Alex Denner and two others to its slate of...Tags: Drugs and Medicines, Qsymia, Companies and Corporations, Biogen Idec Incorporated, Board of Directors
-
ANALYSIS-A hard day to be a short-seller, one of many this year
ReutersBy Ryan Vlastelica NEW YORK, May 9 (Reuters) - Three long-time favorites of the short-selling crowd are making those investors eat crow, as Tesla, Barnes & Noble and Green Mountain Coffee are racking up big gains, making an already painful year for...Tags: Automotive Equipment, Companies and Corporations, Tesla Motors, Inc., Barnes & Noble, Finance
-
The day ahead in business May 8
Reports: MBA mortgage index for week ended May 4, 6:30 a.m.; Crude inventories for week ended May 4, 9:30 a.m. Local earnings: CF Industries Holdings Inc., Groupon Inc., Manitex International Inc., Middleby Corp., MYR Group Inc., Nanosphere Inc.,...
Tags: Groupon, Inc., iPass Incorporated, McDonald's, Tesla Motors, Inc., Standard Parking Corporation
-
U.S. RESEARCH ROUNDUP: Apple, Berkshire Hathaway, Walt Disney, AIG
ReutersMay 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Apple, Berkshire Hathaway and Walt Disney, on Monday. HIGHLIGHTS * Apple : Barclays ups target price to $525 from $465; rating...Tags: YRC Worldwide Incorporated, Global Hunter Corporation, Bio-Rad Laboratories Incorporated, Kraft Foods Group, Inc., Orbotech Limited
-
EU agency backs new Roche, Astellas, Sanofi, Vivus drugs
ReutersLONDON, April 26 (Reuters) - European regulators have recommended approval of two new cancer drugs, called Erivedge and Xtandi, from Roche and Astellas. The European Medicines Agency said on Friday its experts had also backed MAC1, a tissue-engineered...Tags: Drugs and Medicines
-
Nuevo rival para el Viagra
Los hombres con disfunción eréctil quizás no tengan que volver a hacer planes adelantados para tener relaciones sexuales, luego de que Vivus Inc. ganara la aprobación en Estados Unidos de su producto Avanafil, que viene a competir con Viagra, de Pfizer...Tags: Cialis (drug), Drugs and Medicines, Pfizer Inc., Lilly Eli & Co, Viagra (drug)
-
Diet drug Qnexa: Don't get too carried away by new study
The diet drug Qnexa helps obese people with weight-related medical conditions to lose more weight than those who take a dummy pill and could allow some to scale back on medications for diabetes, high blood pressure or cholesterol, according to a new study...Tags: Chemical Industry, Apples, Science and Technology, High Blood Pressure, Placebo
-
FDA shoots down another weight loss drug [Updated]
![The FDA has <a title="Arena Pharmaceuticals' press release" href="http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977" target="_blank">told the makers</a> of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]](http://www.latimes.com/media/thumbnails/story/2010-10/57020075-24134236-187105.JPG "The FDA has <a title="Arena Pharmaceuticals' press release\" href=\"http://invest.arenapharm.com/releasedetail.cfm?ReleaseID=521977\" target=\"_blank\">told the makers</a> of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates in animal studies. [<b>Updated Oct. 25, 10:35 a.m.</b> An earlier version of this article said cancers occurred at higher-than-usual-rates during clinical trials.]")
The FDA has told the makers of the proposed weight-loss drug Lorcaserin that it will not at this time approve the marketing of the medication, citing concerns about its marginal effectiveness and about cancers that occurred at higher-than-usual rates...Tags: Human Body, Trials, San Diego (San Diego, California), Health and Medical Professionals, Crime, Law and Justice
-
Diet drugs face tough test
Tribune NewspapersThere has never been a magic prescription to help millions of obese Americans lose weight. Whether one is any closer to reality is now under scrutiny. A Food and Drug Administration advisory panel will decide Wednesday whether the diet drug Meridia...Tags: Chiropractors, High Blood Pressure, Physical Fitness and Exercise, U.S. Centers for Disease Control and Prevention, Drugs and Medicines
-
Teaming up to save your skin
Daily PressProducts by two Hampton Roads organizations are on the cutting edge of wound care. The nonprofit LifeNet Health in Virginia Beach offers TheraSkin, a graft made of real skin that stimulates your body to heal itself. Soluble Systems of Newport News...Tags: Human Body, Dry Mouth, Social Issues, Chiropractors, Newport News (Newport News, Virginia)
-
The scorecard on obesity drugs: 0 for 3
Los Angeles Times Staff WriterThis is not shaping up to be a good year for people seeking medical help for weight loss. A Food and Drug Administration advisory committee on Thursday voted against recommending approval of the drug lorcaserin. This is the third negative vote on...Tags: Physical Therapists, Cancer, Weight Loss, Health and Medical Professionals, Elections
-
Obesity drugs lumber toward marketplace
Booster ShotsAbout this time last year, we were reporting on the failure of several investigational weight-loss medications. They included Sanofi-Aventis' rimonabant as well as two other drugs that aimed to work by blocking cannabinoid receptors in the brain. However,...
May 23, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Chicago Tribune
May 6, 2013
|Story| Reuters
Apr 26, 2013
|Story| Reuters
Apr 30, 2012
|Story| South Florida Sun-Sentinel
Apr 11, 2011
|Story| Los Angeles Times
Oct 25, 2010
|Story| Los Angeles Times
Sep 15, 2010
|Story| Chicago Tribune
Nov 17, 2010
|Story| Daily Press
Sep 17, 2010
|Story| Los Angeles Times
Oct 28, 2009
| Los Angeles Times
Original site for Vivus Inc. topic gallery.